Jean-Jacques Bienaim

2017

In 2017, Jean-Jacques Bienaim earned a total compensation of $15.9M as Chief Executive Officer at BioMarin Pharmaceutical, a 6% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,726,010
Option Awards$5,253,707
Salary$1,094,423
Stock Awards$7,783,876
Other$58,969
Total$15,916,985

Bienaim received $7.8M in stock awards, accounting for 49% of the total pay in 2017.

Bienaim also received $1.7M in non-equity incentive plan, $5.3M in option awards, $1.1M in salary and $59K in other compensation.

Rankings

In 2017, Jean-Jacques Bienaim's compensation ranked 248th out of 14,666 executives tracked by ExecPay. In other words, Bienaim earned more than 98.3% of executives.

ClassificationRankingPercentile
All
248
out of 14,666
98th
Division
Manufacturing
72
out of 5,770
99th
Major group
Chemicals And Allied Products
19
out of 2,074
99th
Industry group
Drugs
14
out of 1,730
99th
Industry
Pharmaceutical Preparations
13
out of 1,329
99th
Source: SEC filing on April 23, 2019.

Bienaim's colleagues

We found four more compensation records of executives who worked with Jean-Jacques Bienaim at BioMarin Pharmaceutical in 2017.

2017

Henry Fuchs

BioMarin Pharmaceutical

President, Worldwide R&D

2017

Daniel Spiegelman

BioMarin Pharmaceutical

Chief Financial Officer

2017

Jeff Ajer

BioMarin Pharmaceutical

Executive Vice President, Chief Commercial Officer

2017

Robert Baffi

BioMarin Pharmaceutical

Executive Vice President, Technical Operations

News

You may also like